Arbutus Biopharma Corp Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Arbutus Biopharma Corp (ABUS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 9.14 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- Arbutus Biopharma Corp antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 9.14M shares, a 34.94% decline year-over-year.
- Arbutus Biopharma Corp antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 10.37M shares, a 33.42% decline year-over-year.
- Arbutus Biopharma Corp antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 14.05M shares.
- Arbutus Biopharma Corp antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 15.57M shares, a 31.10% decline year-over-year.
- Arbutus Biopharma Corp antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 14.00M shares, a 17.16% decline from fiscal 2024.
- Arbutus Biopharma Corp antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 16.90M shares, a 17.16% decline from fiscal 2023.
- Arbutus Biopharma Corp antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 20.40M shares.
- Arbutus Biopharma Corp antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 11.40M shares, a 64.15% decline from fiscal 2020.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 9.14M shares 10-Q · filed 2026-08-12 | 11.29M shares 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | 10.37M shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 14.00M shares 10-K · filed 2026-03-23 | |||||||
| 2025-06-30 | 14.05M shares 10-Q · filed 2026-08-12 | 15.42M shares 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | 15.57M shares 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | 16.90M shares 10-K · filed 2026-03-23 | |||||||
| 2024-03-31 | 22.60M shares 10-Q · filed 2025-05-14 | |||||||
| 2023-12-31 | 20.40M shares 10-K · filed 2024-03-05 | |||||||
| 2023-09-30 | 21.00M shares 10-Q · filed 2024-11-06 | |||||||
| 2023-06-30 | 20.20M shares 10-Q · filed 2024-08-08 | |||||||
| 2023-03-31 | 19.70M shares 10-Q · filed 2024-05-02 | |||||||
| 2022-09-30 | 15.90M shares 10-Q · filed 2023-11-07 | |||||||
| 2022-06-30 | 15.90M shares 10-Q · filed 2023-08-03 | |||||||
| 2022-03-31 | 15.70M shares 10-Q · filed 2023-05-04 | |||||||
| 2021-12-31 | 11.40M shares 10-K · filed 2023-03-02 | |||||||
| 2021-09-30 | 34.30M shares 10-Q · filed 2022-11-09 | |||||||
| 2021-06-30 | 35.40M shares 10-Q · filed 2022-08-04 | |||||||
| 2021-03-31 | 35.00M shares 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | 31.80M shares 10-K · filed 2022-03-03 | |||||||
| 2020-09-30 | 31.60M shares 10-Q · filed 2021-11-04 | |||||||
| 2020-06-30 | 31.30M shares 10-Q · filed 2021-08-05 | |||||||
| 2020-03-31 | 30.40M shares 10-Q · filed 2021-05-05 | |||||||
| 2019-12-31 | 28.40M shares 10-K · filed 2021-03-04 | 28.36M shares 10-K · filed 2020-03-05 | ||||||
| 2019-09-30 | 28.20M shares 10-Q · filed 2020-11-05 | |||||||
| 2019-06-30 | 27.50M shares 10-Q · filed 2020-08-07 | 28.00M shares 10-Q · filed 2019-08-05 | ||||||
| 2019-03-31 | 26.00M shares 10-Q · filed 2020-05-11 | 26.03M shares 10-Q · filed 2019-05-06 | ||||||
| 2018-12-31 | 24.72M shares 10-K · filed 2020-03-05 | |||||||
| 2018-09-30 | 24.20M shares 10-Q · filed 2019-11-06 | 24.21M shares 10-Q · filed 2018-11-07 | ||||||
| 2018-06-30 | 17.14M shares 10-Q · filed 2018-08-03 | 24.00M shares 10-Q · filed 2019-08-05 | 23.93M shares 10-Q · filed 2018-08-03 | |||||
| 2018-03-31 | 22.10M shares 10-Q · filed 2019-05-06 | |||||||
| 2017-12-31 | 12.52M shares 10-K · filed 2019-03-07 | |||||||
| 2017-09-30 | 5.34M shares 10-Q · filed 2018-11-07 | |||||||
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-03 | 5.85M shares 10-Q · filed 2018-08-03 | ||||||
| 2017-03-31 | 5.96M shares 10-Q · filed 2018-05-04 | |||||||
| 2016-12-31 | 4.65M shares 10-K · filed 2018-03-16 | |||||||
| 2016-09-30 | 4.98M shares 10-Q · filed 2017-11-02 | |||||||
| 2016-06-30 | 5.49M shares 10-Q · filed 2017-08-03 | |||||||
| 2016-03-31 | 7.37M shares 10-Q · filed 2017-05-04 | |||||||
| 2015-12-31 | 2.90M shares 10-K · filed 2018-03-16 | |||||||
| 2015-09-30 | 6.48M shares 10-Q · filed 2016-11-03 | |||||||
| 2015-06-30 | 6.40M shares 10-Q · filed 2016-08-04 | 2.77M shares 10-Q · filed 2015-08-07 | ||||||
| 2015-03-31 | 6.54M shares 10-Q · filed 2016-05-04 | 2.92M shares 10-Q · filed 2015-05-06 | ||||||
| 2014-12-31 | 2.22M shares 10-K · filed 2017-03-22 | |||||||
| 2014-09-30 | 2.36M shares 10-Q · filed 2015-11-05 | |||||||
| 2014-06-30 | 2.56M shares 10-Q · filed 2015-08-07 | |||||||
| 2014-03-31 | 2.57M shares 10-Q · filed 2015-05-06 | |||||||
| 2013-12-31 | 3.06M shares 10-K · filed 2016-03-09 | |||||||
| 2013-09-30 | 3.16M shares 10-Q · filed 2014-11-07 | |||||||
| 2013-06-30 | 3.40M shares 10-Q · filed 2014-08-14 | |||||||
| 2013-03-31 | 3.47M shares 10-Q · filed 2014-05-14 | |||||||
| 2012-12-31 | 1.09M shares 10-K · filed 2015-03-13 | |||||||
| 2011-12-31 | 2.69M shares 10-K · filed 2014-03-28 | 2.83M shares 20-F · filed 2013-03-27 | ||||||
| 2010-12-31 | 1.63M shares 20-F · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |